Skip to Content

Does JAKi Increase the Risk of Cancer in Patients with RA?

Do we need to be aware of cancer risk when treating janus kinase inhibitors (JAKi)? Let Rasmus Westermann, MD, present his study investigating cancer risk in patients with rheumatoid arthritis (RA) treated with JAKi compared to biologics.

Rasmus Westermann

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top